Business
Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development
Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Dev...
About this update from Charlotte's Web Holdings, Inc.
[{"type":"text","content":"\n\n\nPresidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em !IMPORTANT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nCanada NewsWire\n\n\nDeFloria Advancing Charlotte's Web Legacy as Pioneer in Cannabinoid Health, with Phase 2 Clinical Trials for Autism Botanical Drug\nLOUISVILLE, Colo. and WASHINGTON, Dec. 19, 2025 /CNW/ - DeFloria Inc., a botanical drug development Company recognizes the Presidential Executive Order to reclassify cannabis from Schedule I to Schedule III, as a critical accelerator for cannabinoid medical innovation and regulatory reform. DeFloria is advancing a leading cannabinoid-based investigational new drug (\"IND\") through the FDA botanical drug pathway for autism-related irritability (AJA001 oral solution). The Executive Order represents pivotal federal acknowledgment of the therapeutic value of cannabinoids and validates a patient-centered movement that began more than a decade ago with the Stanley Brothers and their founding of Charlotte's Web (TSX: CWEB) (OTCQB: CWBHF).\n\n\n\n\n\n\n\n\"Charlotte's Web ignited the era of cannabinoid medicine, and DeFloria is the next chapter, elevating that mission with scientific rigor and FDA pathways,\" said Joel Stanley, Co-Founder of Charlotte's Web and Chair of the DeFloria Board. \"Federal policy is finally catching up to what patients, academics, and clinicians have long understood: cannabinoids hold real therapeutic power. DeFloria exists to transform that promise into approved medicines that change lives.\"\nBorn from the founders of Charlotte's Web - the market leading brand that defined CBD and reshaped the national dialogue - DeFloria is leveraging years of real-world medicinal benefits and patient experience that sparked the early momentum that led to this moment. Building on legacy and data, DeFloria is driving an entirely new category of FDA-regulated botanical drug development.\nFounders' Long-Standing Vision Gains Historic Federal Level Validation\nYears before federal p...